Debra L. Breneman

Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study.

J. Koo, D. Piacquadio, L. Edwards, 1998, Clinical therapeutics.

Administration of DAB389IL-2 to patients with recalcitrant psoriasis: a double-blind, phase II multicenter trial.

M. Holick, D. Fivenson, W. T. Garland, 1998, Journal of the American Academy of Dermatology.

Isolation of human immunodeficiency virus type 1 in cutaneous blister fluid.

C. Linnemann, D. Breneman, N. Supapannachart, 1991, Archives of dermatology.